bioAffinity Technologies, Inc.
BIAF
$0.245
$0.0062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.06M | -2.66M | -2.97M | -2.00M | -2.11M |
| Total Depreciation and Amortization | 113.20K | 154.60K | 153.60K | 151.30K | 151.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.27M | 326.60K | 234.10K | 185.70K | 286.20K |
| Change in Net Operating Assets | 25.90K | 537.40K | 902.00K | -45.40K | 140.60K |
| Cash from Operations | -2.65M | -1.64M | -1.68M | -1.71M | -1.53M |
| Capital Expenditure | -13.40K | -50.80K | 0.00 | -9.40K | -28.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.40K | -50.80K | 0.00 | -9.40K | -28.30K |
| Total Debt Issued | -- | -- | -96.90K | 261.90K | -900.00 |
| Total Debt Repaid | -167.00K | -139.20K | -91.00K | -91.00K | -90.40K |
| Issuance of Common Stock | 3.19M | 1.17M | 2.21M | 1.50M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -494.90K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 495.00K |
| Cash from Financing | 3.02M | 1.03M | 2.03M | 1.67M | -91.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 358.10K | -660.60K | 348.70K | -44.70K | -1.65M |